Author Index

A

  • Abdelhamid, Dalia Design, synthesis in vitro and in vivo evaluation of new diaryltriazoles carboxylic and hydroxamic acid derivatives as inhibitors of tumor necrosis alpha converting enzyme (TACE) [Volume 2, Issue 1, 2023, Pages 44-62]
  • Abourhma, Gamal Synthesis, Molecular Modeling and Anticancer Activity of New Rescinnamine Derivatives as MMR-Inducers [Volume 2, Issue 1, 2023, Pages 21-35]
  • Aly, Omar Synthesis, Molecular Modeling and Anticancer Activity of New Rescinnamine Derivatives as MMR-Inducers [Volume 2, Issue 1, 2023, Pages 21-35]
  • Aly, Omar Design, synthesis in vitro and in vivo evaluation of new diaryltriazoles carboxylic and hydroxamic acid derivatives as inhibitors of tumor necrosis alpha converting enzyme (TACE) [Volume 2, Issue 1, 2023, Pages 44-62]

B

  • Badran, Mostafa M. Design, synthesis in vitro and in vivo evaluation of new diaryltriazoles carboxylic and hydroxamic acid derivatives as inhibitors of tumor necrosis alpha converting enzyme (TACE) [Volume 2, Issue 1, 2023, Pages 44-62]

D

  • Diamanduros, Andrew Synthesis, Molecular Modeling and Anticancer Activity of New Rescinnamine Derivatives as MMR-Inducers [Volume 2, Issue 1, 2023, Pages 21-35]

E

  • El-Abasawy, Nasr M. Determination of alogliptin benzoate and pioglitazone hydrochloride in their dosage forms, validation and stability-indicating studies using RP-HPLC method. [Volume 2, Issue 1, 2023, Pages 1-10]
  • EL-Olemy, Ahmed Determination of alogliptin benzoate and pioglitazone hydrochloride in their dosage forms, validation and stability-indicating studies using RP-HPLC method. [Volume 2, Issue 1, 2023, Pages 1-10]

F

  • Fouad, Ali Determination of alogliptin benzoate and pioglitazone hydrochloride in their dosage forms, validation and stability-indicating studies using RP-HPLC method. [Volume 2, Issue 1, 2023, Pages 1-10]

H

  • Hassan, Abdelfattah Design, synthesis in vitro and in vivo evaluation of new diaryltriazoles carboxylic and hydroxamic acid derivatives as inhibitors of tumor necrosis alpha converting enzyme (TACE) [Volume 2, Issue 1, 2023, Pages 44-62]
  • Hassan, Heba A. Design, synthesis in vitro and in vivo evaluation of new diaryltriazoles carboxylic and hydroxamic acid derivatives as inhibitors of tumor necrosis alpha converting enzyme (TACE) [Volume 2, Issue 1, 2023, Pages 44-62]

K

  • King, Stephen Synthesis, Molecular Modeling and Anticancer Activity of New Rescinnamine Derivatives as MMR-Inducers [Volume 2, Issue 1, 2023, Pages 21-35]

R

  • Ramadan, Ahmed Mohammed A potential therapy for the Rheumatoid Arthritis: New drug discovery [Volume 2, Issue 1, 2023, Pages 11-20]

S

  • Salsbury, Freddie Synthesis, Molecular Modeling and Anticancer Activity of New Rescinnamine Derivatives as MMR-Inducers [Volume 2, Issue 1, 2023, Pages 21-35]
  • Saraya, Roshdy elsayed Review article on instrumental analysis of Molnupiravir, Favipiravir, and Ritonavir in different matrices [Volume 2, Issue 1, 2023, Pages 36-43]
  • Scarpinato, Karin Synthesis, Molecular Modeling and Anticancer Activity of New Rescinnamine Derivatives as MMR-Inducers [Volume 2, Issue 1, 2023, Pages 21-35]
  • Sharaf El-din, Mohamed M. Determination of alogliptin benzoate and pioglitazone hydrochloride in their dosage forms, validation and stability-indicating studies using RP-HPLC method. [Volume 2, Issue 1, 2023, Pages 1-10]